UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057717
Receipt number R000065947
Scientific Title Investigation of the relationship between ameloblastoma and salivary uric acid levels and microRNAs
Date of disclosure of the study information 2025/04/25
Last modified on 2025/04/25 14:47:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the relationship between ameloblastoma and salivary uric acid levels and microRNAs

Acronym

Uric acid levels and miRNAs in patients with ameloblastoma

Scientific Title

Investigation of the relationship between ameloblastoma and salivary uric acid levels and microRNAs

Scientific Title:Acronym

Uric acid levels and miRNAs in patients with ameloblastoma

Region

Japan


Condition

Condition

ameloblastoma

Classification by specialty

Oral surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Extract new clinical markers for ameloblastoma by identifying the relationship between ameloblastoma and uric acid levels and miRNAs associated with with cell proliferation.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Salivary uric acid levels

Key secondary outcomes

,miRNAs associated with cell proliferation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Gene Other

Interventions/Control_1

Measuring salivary uric acid levels and miRNAs involved in cell proliferation in patients with ameloblastoma.

Interventions/Control_2

Measuring salivary uric acid levels and miRNAs involved in cell proliferation in healthy subjects.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient group
(1) Patients who have been diagnosed with enamel epithelioma (postoperative and scheduled surgery patients) in Department of Oral and Maxillofacial Surgery, Fukuoka Dental College Hospital.
(2) Patients who fully understand this research plan and can give informed consent by themselves or their family (parents and guardians of minors).
(3) Age 16 years or older at the time of obtaining informed consent.
Control group
(1) Patients who visit the outpatient dental clinic of Fukuoka Dental College Hospital with the main complaint of seeking dental treatment and are diagnosed as having no history of systemic diseases including ameloblastoma.
(2) Patients who fully understand this research plan and can give informed consent by themselves or their family members.

Key exclusion criteria

Patient group
(1) Patients who could not obtain consent.
(2) Patients who are under treatment for or have a history of malignancy including oral cancer.
(3) Other patients whom the investigator judges to be inappropriate as research subjects.
(4) When consent is withdrawn during the study.
Control group
(1) Patients who could not obtain consent.
(2) Patients who are under treatment for or have a history of malignancy including oral cancer.
(3) Other patients whom the investigator judged to be inappropriate as research subjects.
(4) In case of withdrawal of consent during the course of the study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiromitsu
Middle name
Last name Morita

Organization

Fukuoka Dental College

Division name

Section of Dentistry for the Disabled, Department of Oral Growth and Development

Zip code

814-0193

Address

Tamura 2-15-1, Sawara-ku, Fukuoka

TEL

092-801-0425

Email

morita@fdcnet.ac.jp


Public contact

Name of contact person

1st name Hiromitsu
Middle name
Last name Morita

Organization

Fukuoka Dental College

Division name

Section of Dentistry for the Disabled, Department of Oral Growth and Development

Zip code

814-0193

Address

Tamura 2-15-1, Sawara-ku, Fukuoka

TEL

092-801-0425

Homepage URL


Email

morita@fdcnet.ac.jp


Sponsor or person

Institute

Fukuoka Dental College

Institute

Department

Personal name

Hiromitsu Morita


Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka Dental College

Address

Tamura 2-15-1, Sawara-ku, Fukuoka

Tel

092-801-0425

Email

shomu@fdcnet.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福岡歯科大学医科歯科総合病院


Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 05 Month 10 Day

Date of IRB

2024 Year 05 Month 10 Day

Anticipated trial start date

2024 Year 05 Month 10 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 04 Month 25 Day

Last modified on

2025 Year 04 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065947